Join a Clinical Trial
Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each clinical trial.
Clinical Trial Details
HCT Using Treosulfan for Bone Marrow Failure Diseases (BMT CTN 1904)
Complete Title: Hematopoietic Cell Transplantation Using Treosulfan-Based Conditioning for the Treatment of Bone Marrow Failure Diseases: BMT CTN PROTOCOL 1904
Trial Phase: II
Investigator: Lauri Burroughs
This is a prospective, multicenter phase II study designed to evaluate the outcomes of patients with bone marrow failure diseases (BMFD) undergoing HLA-matched related, HLA-matched unrelated, or single HLA-class 1 allele or HLA-DQB1 antigen or allele mismatched unrelated hematopoietic cell transplantation (HCT) using treosulfan-based conditioning.
Keywords:
- Bone Marrow Transplant / Hematopoietic Stem Cell Transplant (BMT/HSCT)
Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.
Contact Us
If you are seeking to schedule an appointment, we are here to help. You can either call us or fill out our online appointment request form.
Adult
Pediatric
II
Lauri Burroughs
RG1121820
NCT04965597
Hematopoietic Cell Transplantation Using Treosulfan-Based Conditioning for the Treatment of Bone Marrow Failure Diseases: BMT CTN PROTOCOL 1904
Bone Marrow Transplant / Hematopoietic Stem Cell Transplant (BMT/HSCT)